🇪🇺 UMECLIDINIUM BROMIDE in European Union

UMECLIDINIUM BROMIDE (UMECLIDINIUM BROMIDE) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/002809
  • Local brand name: Incruse Ellipta (previously Incruse)
  • Status: approved

UMECLIDINIUM BROMIDE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is UMECLIDINIUM BROMIDE approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for UMECLIDINIUM BROMIDE in European Union?

Marketing authorisation holder not available in our data.